ID28343A - Kaprolaktam tersubstitusi tertentu, komposisi farmasi yang mengandungnya dan penggunaannya dalam pengobatan tumor - Google Patents

Kaprolaktam tersubstitusi tertentu, komposisi farmasi yang mengandungnya dan penggunaannya dalam pengobatan tumor

Info

Publication number
ID28343A
ID28343A IDW00200100966A ID20010966A ID28343A ID 28343 A ID28343 A ID 28343A ID W00200100966 A IDW00200100966 A ID W00200100966A ID 20010966 A ID20010966 A ID 20010966A ID 28343 A ID28343 A ID 28343A
Authority
ID
Indonesia
Prior art keywords
capacolakam
certained
substituted
tumor treatment
pharmacy composition
Prior art date
Application number
IDW00200100966A
Other languages
English (en)
Inventor
Frederick R Kinder
Kenneth W Bair
Christopher T Jagoe
Richard W Versace
Sompong Wattanasin
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of ID28343A publication Critical patent/ID28343A/id

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
    • C07D223/02—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D223/06—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom not condensed with other rings with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D223/08—Oxygen atoms
    • C07D223/10—Oxygen atoms attached in position 2
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Plural Heterocyclic Compounds (AREA)
IDW00200100966A 1998-11-17 1999-11-15 Kaprolaktam tersubstitusi tertentu, komposisi farmasi yang mengandungnya dan penggunaannya dalam pengobatan tumor ID28343A (id)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US19335498A 1998-11-17 1998-11-17

Publications (1)

Publication Number Publication Date
ID28343A true ID28343A (id) 2001-05-17

Family

ID=22713307

Family Applications (1)

Application Number Title Priority Date Filing Date
IDW00200100966A ID28343A (id) 1998-11-17 1999-11-15 Kaprolaktam tersubstitusi tertentu, komposisi farmasi yang mengandungnya dan penggunaannya dalam pengobatan tumor

Country Status (25)

Country Link
EP (1) EP1131297B1 (id)
JP (1) JP3550545B2 (id)
KR (1) KR20010080461A (id)
CN (1) CN1187333C (id)
AR (1) AR023914A1 (id)
AT (1) ATE264309T1 (id)
AU (1) AU748016B2 (id)
BR (1) BR9915436A (id)
CA (1) CA2347773C (id)
CO (1) CO5140099A1 (id)
CZ (1) CZ20011707A3 (id)
DE (1) DE69916488T2 (id)
ES (1) ES2221463T3 (id)
HU (1) HUP0104224A3 (id)
ID (1) ID28343A (id)
IL (1) IL142701A0 (id)
NO (1) NO20012428L (id)
PE (1) PE20001241A1 (id)
PL (1) PL347633A1 (id)
PT (1) PT1131297E (id)
SK (1) SK6692001A3 (id)
TR (1) TR200101366T2 (id)
UY (2) UY25807A1 (id)
WO (1) WO2000029382A1 (id)
ZA (1) ZA200103419B (id)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2299515T3 (es) * 2000-05-11 2008-06-01 Novartis Ag Carbonatos y eteres de caprolactama sustituidos y su uso como agentes antitumorales.
US6545148B2 (en) 2001-03-12 2003-04-08 Novartis Ag Process for preparing certain substituted caprolactams
CN1856486A (zh) 2003-07-25 2006-11-01 诺瓦提斯公司 取代的内酰胺和它们作为抗癌剂的用途
US7153846B2 (en) 2003-10-24 2006-12-26 Sanofi-Aventis Deutschland Gmbh Bengamide derivatives, process for preparing them, and their use
DE10349669B3 (de) * 2003-10-24 2005-05-25 Aventis Pharma Deutschland Gmbh Bengamide-Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung
FR2878525B1 (fr) * 2004-11-29 2007-02-23 Aventis Pharma Sa Bengamides possedant un cycle caprolactame substitue, procede de preparation, compositions les contenant et utilisation
FR2878528B1 (fr) * 2004-11-29 2008-05-16 Aventis Pharma Sa 2-alcoxy-3,4,5-trihydroxy-alkylamides, leur preparation, compositions les contenant et utilisation
FR2901555A1 (fr) 2006-05-24 2007-11-30 Sanofi Aventis Sa 2-alcoxy-3,4,5-trihydroxy-alkylamide-benzothiazepine, leur preparation, compositions les contenant et utilisation
FR2901556A1 (fr) * 2006-05-24 2007-11-30 Sanofi Aventis Sa Derives de 2-alcoxy-3,4,5-trihydroxy-alkylamide, leur preparation, compositions les contenant et utilisation
FR2901554B1 (fr) 2006-05-24 2011-04-01 Sanofi Aventis 2-alcoxy-3,4,5-trihydroxy-alkylamide-benzazepine, leur preparation, compositions les contenant et utilisation
CN102947274A (zh) 2010-06-17 2013-02-27 诺瓦提斯公司 联苯基取代的1,3-二氢-苯并咪唑-2-亚基胺衍生物
EP2582681A1 (en) 2010-06-17 2013-04-24 Novartis AG Piperidinyl substituted 1,3-dihydro-benzoimidazol-2-ylideneamine derivatives

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9411841D0 (en) * 1994-06-14 1994-08-03 Pharma Mar Sa New antitumoral compounds from jaspis sponge

Also Published As

Publication number Publication date
CA2347773C (en) 2009-03-10
CN1326445A (zh) 2001-12-12
JP3550545B2 (ja) 2004-08-04
AR023914A1 (es) 2002-09-04
ES2221463T3 (es) 2004-12-16
TR200101366T2 (tr) 2001-10-22
PL347633A1 (en) 2002-04-22
WO2000029382A1 (en) 2000-05-25
HUP0104224A2 (hu) 2002-03-28
UY25807A1 (es) 2001-08-27
PT1131297E (pt) 2004-08-31
EP1131297B1 (en) 2004-04-14
JP2002529536A (ja) 2002-09-10
KR20010080461A (ko) 2001-08-22
AU748016B2 (en) 2002-05-30
DE69916488D1 (de) 2004-05-19
BR9915436A (pt) 2001-08-07
ATE264309T1 (de) 2004-04-15
CN1187333C (zh) 2005-02-02
IL142701A0 (en) 2002-03-10
SK6692001A3 (en) 2001-10-08
HUP0104224A3 (en) 2002-04-29
CA2347773A1 (en) 2000-05-25
CZ20011707A3 (cs) 2001-08-15
EP1131297A1 (en) 2001-09-12
UY26036A1 (es) 2001-06-29
NO20012428L (no) 2001-07-17
DE69916488T2 (de) 2005-03-24
CO5140099A1 (es) 2002-03-22
PE20001241A1 (es) 2000-11-24
ZA200103419B (en) 2002-06-26
AU1506000A (en) 2000-06-05
NO20012428D0 (no) 2001-05-16

Similar Documents

Publication Publication Date Title
ID25528A (id) Karboksamidotiazol tersubstitusi, pembuatannya dan komposisi farmasi yang mengandungnya
ID21529A (id) Metode dan komposisi untuk pengobatan dan pencegahan tumor, gangguan yang berhubungan dengan tumor dan kakeksia
DE69929047D1 (de) Haarbehandlungsmittel
ID21863A (id) Senyawa kinolin dan kinazolin yangberguna dalam terapi, khususnya dalam pengobatan heperplasia prostatik jinak
ID22889A (id) Komposisi kopolimer etilena dan penggunaannya
HUP0200442A3 (en) Azeotrope-like composition comprising 1,1,1,3,3-pentafluorobutane and its use
ID21019A (id) Turunan pirazol, pembuatannya dan penggunaannya dalam sediaan farmasi
BR9712948B1 (pt) unidade de terapia por fàtons e cabeÇote para tratamento de terapia de fàtons.
ID28576A (id) Aparatus pelindung untuk penggunaan dalam hubungannya dengan perkakas sumuran dan metode untuk perlindungan kumparan
ID28787A (id) 2-fenilbenzimidazol tersubstitusi, pembuatannya dan penggunaannya
FR2759581B1 (fr) Dispositif de traitement, notamment par moxa, de type acupressure
ZA200202996B (en) Hair treatment compositions comprising particulate substances.
PT1017408E (pt) Utilizacao de tetra-hidrolipstatina no tratamento de diabetes de tipo ii
HUP0400069A3 (en) Pharmaceutical combinations and their use in preventing and treating the thrombosis
ZA991974B (en) Bicyclic aromatic compounds and their use in human or veterinary medicine, as well as in cosmetology.
EE200300473A (et) Tsüano-asendatud dihüdropürimidiinühendid ja nende kasutamine haiguste raviks
MXPA03008634A (es) Nuevos compuestos de dihidropirimidina ciano sustituidos y su uso para tratar enfermedades.
ID22660A (id) Turunan-turunan piridina dan komposisi farmasi yang mengandungnya
HUP0303243A3 (en) Carbamate compounds for use in preventing and treating bipolar disorder
ID29249A (id) Turunan-turunan 1,3-diaril-2-pirid-2-il-3-(pirid-2-ilamino) propanol tersubstitusi, metode-metode pembuatannya, zat-zat farmasi yang mengandung senyawa-senyawa ini dan penggunaannya
ID19813A (id) Benzotiofen, formulasi yang mengandungnya, dan metodenya
ZA200210316B (en) Composition and its therapeutic use.
NO20012428D0 (no) Substituerte kaprolaktamer, farmasöytiske sammensetninger som inneholder dem og deres anvendelse ved behandling av tumorer
AU2002340251A8 (en) Use of mx gtpases in the prognosis and treatment of cancer
BR0012043B1 (pt) composiÇço de tratamento de cabelo.